Nikita Singh

Nikita Singh is a scientist at Myelo Therapeutics GmbH since June 2022 and a doctoral student at Charité since February 2019, possessing extensive experience in molecular, immunological, and cellular techniques. Skills include molecular biology techniques such as cloning, PCR, RT-qPCR, and CRISPR/Cas9, along with expertise in protein isolation, microbiology, and immunology techniques. Previous experience includes a doctoral student role at Klinikum Rechts der Isar der Technischen Universität München and a student research assistant position at the Institut für Allgemeine Botanik und Pflanzenphysiologie, which involved functional characterization of the C3 subunit in Chlamydomonas reinhardtii. Nikita Singh holds a PhD in Oncology and Cancer Biology from Charité, a Master's Degree in Molecular Life Science from Friedrich Schiller University Jena, and a Bachelor's Degree in Genetic Engineering from SRM University, complemented by earlier public relations and retail process experience at GymChalo.com and Amazon.com.